TrimRX
US$ 27.29
pharma news today obesity drugs glp-1 health october 2025 Outlook for obesity in 2025: more GLP-1 drugs changed the obesity
Description
GLP-1 receptor agonists (GLP-1s) are a class of drugs approved for treating diabetes and obesity
He J, Wang C, Sun Y, et al
Elizabeth Kenly, 59, of Graham, North Carolina, said she asked her doctor this month to see if her insurance would cover Zepbound for sleep apnea
This dual action makes it a powerful tool for those struggling with diabetes
This is exciting because while presently there are already 3 FDA approved medications for alcohol use disorder, their effects are modest
Practices that stay current on these developments and adapt their protocols accordingly will continue to deliver better outcomes
